A Novel IRAK1-IKKε signaling axis limits the activation of TAK1-IKKβ downstream of TLR3

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2844-2856

  Bruni, Daniela ^a   Sebastia, Jordi ^a   Dunne, Susan ^a   Schröder, Martina ^a   Butler, Marion P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; I KAPPA B KINASE BETA; I KAPPA B KINASE EPSILON; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME REGULATION; HUMAN; HUMAN CELL; MACROPHAGE; METABOLIC ACTIVATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CARRIER PROTEINS; CELL LINE; DOWN-REGULATION; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MICE; MICROGLIA; PROTEIN INTERACTION MAPPING; TOLL-LIKE RECEPTOR 3;

EID: 84874918453     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202042     Document Type: Article

References (40)

1. Uematsu, S., S. Sato, M. Yamamoto, T. Hirotani, H. Kato, F. Takeshita, M. Matsuda, C. Coban, K. J. Ishii, T. Kawai, et al. 2005. Interleukin-1 receptorassociated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-alpha induction. J. Exp. Med. 201: 915-923.
2. An, H., J. Hou, J. Zhou, W. Zhao, H. Xu, Y. Zheng, Y. Yu, S. Liu, and X. Cao. 2008. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9: 542-550.
3. Jiang, Z., T. W. Mak, G. Sen, and X. Li. 2004. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domaincontaining adapter inducing IFN-beta. Proc. Natl. Acad. Sci. USA 101: 3533- 3538.
4. Sato, S., M. Sugiyama, M. Yamamoto, Y. Watanabe, T. Kawai, K. Takeda, and S. Akira. 2003. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171: 4304-4310.
5. Marty, C., C. Meylan, H. Schott, K. Ballmer-Hofer, and R. A. Schwendener. 2004. Enhanced heparan sulfate proteoglycan-mediated uptake of cellpenetrating peptide-modified liposomes. Cell. Mol. Life Sci. 61: 1785-1794.
6. Cusson-Hermance, N., S. Khurana, T. H. Lee, K. A. Fitzgerald, and M. A. Kelliher. 2005. Rip1 mediates the Trif-dependent toll-like receptor 3- and 4-induced NF-kappaB activation but does not contribute to interferon regulatory factor 3 activation. J. Biol. Chem. 280: 36560-36566.
7. Shim, J. H., C. Xiao, A. E. Paschal, S. T. Bailey, P. Rao, M. S. Hayden, K. Y. Lee, C. Bussey, M. Steckel, N. Tanaka, et al. 2005. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 19: 2668-2681.
8. Xia, Z. P., L. Sun, X. Chen, G. Pineda, X. Jiang, A. Adhikari, W. Zeng, and Z. J. Chen. 2009. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461: 114-119.
9. Wang, C., L. Deng, M. Hong, G. R. Akkaraju, J. Inoue, and Z. J. Chen. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351.
10. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278: 860-866.
11. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IkappaB kinase that activates the transcription factor NFkappaB. Nature 388: 548-554.
12. Adli, M., and A. S. Baldwin. 2006. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 281: 26976-26984.
13. Viatour, P., M. P. Merville, V. Bours, and A. Chariot. 2005. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30: 43-52.
14. Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274: 30353-30356.
15. Sato, S., H. Sanjo, K. Takeda, J. Ninomiya-Tsuji, M. Yamamoto, T. Kawai, K. Matsumoto, O. Takeuchi, and S. Akira. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6: 1087-1095.
16. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda, and S. Akira. 2004. The roles of two IkappaB kinaserelated kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199: 1641-1650.
17. Tenoever, B. R., S. L. Ng, M. A. Chua, S. M. McWhirter, A. García-Sastre, and T. Maniatis. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315: 1274-1278.
18. Basagoudanavar, S. H., R. J. Thapa, S. Nogusa, J. Wang, A. A. Beg, and S. Balachandran. 2011. Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses. J. Virol. 85: 2599-2610.
19. Wang, J., S. H. Basagoudanavar, X. Wang, E. Hopewell, R. Albrecht, A. García- Sastre, S. Balachandran, and A. A. Beg. 2010. NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication. J. Immunol. 185: 1720-1729.
20. Clark, K., M. Peggie, L. Plater, R. J. Sorcek, E. R. Young, J. B. Madwed, J. Hough, E. G. McIver, and P. Cohen. 2011. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434: 93-104.
21. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta Delta C(T)) Method. Methods 25: 402-408.
22. Saitoh, T., M. Yamamoto, M. Miyagishi, K. Taira, M. Nakanishi, T. Fujita, S. Akira, N. Yamamoto, and S. Yamaoka. 2005. A20 is a negative regulator of IFN regulatory factor 3 signaling. J. Immunol. 174: 1507-1512.
23. Wang, Y. Y., L. Y. Li, K. J. Han, Z. H. Zhai, and H. B. Shu. 2004. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett. 576: 86-90.
24. Tzieply, N., A. M. Kuhn, D. Morbitzer, D. Namgaladze, A. Heeg, L. Schaefer, A. von Knethen, L. E. Jensen, and B. Brüne. 2012. OxLDL inhibits LPS-induced IFNb expression by Pellino3- and IRAK1/4-dependent modification of TANK. Cell. Signal. 24: 1141-1149.
25. McWhirter, S. M., K. A. Fitzgerald, J. Rosains, D. C. Rowe, D. T. Golenbock, and T. Maniatis. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101: 233-238.
26. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
27. Tsiloyiannis, V. K., S. C. Kyriakis, J. Vlemmas, and K. Sarris. 2001. The effect of organic acids on the control of post-weaning oedema disease of piglets. Res. Vet. Sci. 70: 281-285.
28. Zhang, B., M. Li, L. Chen, K. Yang, Y. Shan, L. Zhu, S. Sun, L. Li, and C. Wang. 2009. The TAK1-JNK cascade is required for IRF3 function in the innate immune response. Cell Res. 19: 412-428.
29. Hou, J., P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao. 2009. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183: 2150- 2158.
30. Kim, T. W., K. Staschke, K. Bulek, J. Yao, K. Peters, K. H. Oh, Y. Vandenburg, H. Xiao, W. Qian, T. Hamilton, et al. 2007. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity. J. Exp. Med. 204: 1025- 1036.
31. Kawagoe, T., S. Sato, A. Jung, M. Yamamoto, K. Matsui, H. Kato, S. Uematsu, O. Takeuchi, and S. Akira. 2007. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J. Exp. Med. 204: 1013-1024.
32. Chiang, E. Y., X. Yu, and J. L. Grogan. 2011. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types. J. Immunol. 186: 1279-1288.
33. Ng, S. L., B. A. Friedman, S. Schmid, J. Gertz, R. M. Myers, B. R. Tenoever, and T. Maniatis. 2011. IkB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. USA 108: 21170-21175.
34. Paz, S., M. Vilasco, S. J. Werden, M. Arguello, D. Joseph-Pillai, T. Zhao, T. L. Nguyen, Q. Sun, E. F. Meurs, R. Lin, and J. Hiscott. 2011. A functional Cterminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res. 21: 895-910.
35. Clark, K., O. Takeuchi, S. Akira, and P. Cohen. 2011. The TRAF-associated protein TANK facilitates cross-talk within the IkappaB kinase family during Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 108: 17093-17098.
36. Lin, R., J. Lacoste, P. Nakhaei, Q. Sun, L. Yang, S. Paz, P. Wilkinson, I. Julkunen, D. Vitour, E. Meurs, and J. Hiscott. 2006. Dissociation of a MAVS/ IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 80: 6072-6083.
37. Bonnard, M., C. Mirtsos, S. Suzuki, K. Graham, J. Huang, M. Ng, A. Itié, A. Wakeham, A. Shahinian, W. J. Henzel, et al. 2000. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19: 4976-4985.
38. Marchlik, E., P. Thakker, T. Carlson, Z. Jiang, M. Ryan, S. Marusic, N. Goutagny, W. Kuang, G. R. Askew, V. Roberts, et al. 2010. Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality. J. Leukoc. Biol. 88: 1171-1180.
39. Gerondakis, S., R. Grumont, R. Gugasyan, L. Wong, I. Isomura, W. Ho, and A. Banerjee. 2006. Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 25: 6781- 6799.
40. Kawagoe, T., O. Takeuchi, Y. Takabatake, H. Kato, Y. Isaka, T. Tsujimura, and S. Akira. 2009. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat. Immunol. 10: 965- 972.